XML 72 R53.htm IDEA: XBRL DOCUMENT v3.25.0.1
Acquisitions and Divestitures (Tables)
 12 Months Ended
Dec. 31, 2024
Business Combinations [Abstract]  
Schedule of Components of Routine Acquisitions
During 2024, 2023 and 2022, the Company acquired other dialysis and related businesses for consideration paid in cash.
As part of these other international and routine transactions in 2024, the Company acquired a controlling interest in a previously nonconsolidated U.S. dialysis partnership for which it recognized a non-cash gain of $35,147 on its prior investment upon consolidation. The Company estimated the fair value of its previously held equity interest in this business using appraisals developed with independent third party valuation firms.
Aggregate consideration – DVC and all other acquisitions
Aggregate consideration for both the DaVita Care Pte. Ltd. acquisition and all other international and routine acquisitions described above has been as follows:
Year ended December 31,
202420232022
Cash paid$329,187 $27,648 $59,271 
Contingent purchase price and liabilities assumed50,384 19,801 19,337 
Fair value of previously held equity interests182,270 — — 
Aggregate consideration$561,841 $47,449 $78,608 
Number of dialysis centers acquired — U.S.12—5
Number of dialysis centers acquired — International1981211
Aggregate Purchase Cost Allocations for Acquisitions
The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:
 Year ended December 31,
 202420232022
Cash $83,119 $1,254 $1,963 
Other current assets249,738 6,128 6,389 
Property and equipment94,951 4,130 7,481 
Right-of-use lease assets and other long-term assets97,591 785 1,066 
Indefinite-lived licenses22,725 15,789 19,610 
Goodwill349,069 25,723 49,047 
Liabilities assumed(201,704)(6,179)(6,081)
Noncontrolling interests assumed(133,648)(181)(867)
$561,841 $47,449 $78,608 
Schedule of other information related to acquired intangibles and goodwill The amount of goodwill related to these acquisitions recognized or adjusted in 2024, 2023 and 2022 that is deductible for local tax purposes was $54,810, $17,836 and $49,047, respectively.
Pro Forma Summary of Results of Operations
The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions in 2024 and 2023 had been consummated as of the beginning of 2023, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.
 Year ended December 31,
 20242023
 (unaudited)
Pro forma total revenues$13,073,083 $12,625,223 
Pro forma net income attributable to DaVita Inc.$952,836 $732,265 
Pro forma basic net income per share attributable to DaVita Inc.$11.21 $8.07 
Pro forma diluted net income per share attributable to DaVita Inc.$10.92 $7.86